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Coordinated interactions between T and B cells are crucial for inducing physiological B
cell responses. Mutant mice in which tyrosine 136 of linker for activation of T cell (LAT)
is replaced by a phenylalanine (LatY136F) exhibit a strong CD4+ T cell proliferation in the
absence of intended immunization. The resulting effector T cells produce high amounts
of TH2 cytokines and are extremely efﬁcient at inducing polyclonal B cell activation. As a
consequence, these LatY136F mutant mice showed massive germinal center formations
and hypergammaglobulinemia. Here, we analyzed the involvement of different costimu-
lators and their ligands in such T–B interactions both in vitro and in vivo, using blocking
antibodies, knockout mice, and adoptive transfer experiments. Surprisingly, we showed
in vitro that although B cell activation required contact with T cells, CD40, and inducible T
cell costimulator molecule-ligand (ICOSL) signaling were not necessary for this process.
These observations were further conﬁrmed in vivo, where none of these molecules were
required for the unfolding of the LAT CD4+ T cell expansion and the subsequent poly-
clonal B cell activation, although, the absence of CD40 led to a reduction of the follicular B
cell response. These results indicate that the crucial functions played by CD40 and ICOSL
in germinal center formation and isotype switching in physiological humoral responses
are partly overcome in LatY136F mice. By comparison, the absence of CD80–CD86 was
found to almost completely block the in vitro B cell activation mediated by LatY136F CD4+
T cells. The role of CD80–CD86 in T–B cooperation in vivo remained elusive due to the
upstream implication of these costimulatory molecules in the expansion of LatY136F CD4+
T cells. Together, our data suggest that CD80 and CD86 costimulators play a key role in
the polyclonal B cell activation mediated by LatY136F CD4+ T cells even though additional
costimulatory molecules or cytokines are likely to be required in this process.
Keywords: costimulation,T–B synapse, humoral immunity
INTRODUCTION
The humoral immune response that is responsible for provid-
ing long-lasting immunity against pathogens depends in large on
T-dependent B cell activation. Since B cells are less stringently
selected than T cells during their development (Adelstein et al.,
1991), their activation in the periphery has to be tightly regu-
latedwhen they give rise to extrafollicular short-livedplasmablasts,
germinal center B cells, high afﬁnity long-lived plasma cells and
memory B cells (Wardemann et al., 2003; McHeyzer-Williams
andMcHeyzer-Williams,2004).Accordingly, complex interactions
between B and T cells are required to trigger fully ﬂedged humoral
responses, but also to avoid the generation of antibodies against
self-components. The generation of effector B cells requires the
formation of an immune synapse between antigen-primed B cells
and T helper cells (Fazilleau et al., 2009). This synapse, which is
Abbreviations: ICOSL, inducible T cell costimulator ligand; LAT, linker for
activation of T cells; SLAM, signaling lymphocyte activation molecule.
stabilized by intercellular adhesion molecules such as LFA-1 and
its ICAM1 ligand, comprises an antigen-speciﬁc component that
involves peptide loaded MHC class II (MHCII) molecules on the
surface of the antigen-primed B cells and the T cell antigen recep-
tor (TCR) expressed on the surface of T cells. This last interaction
is essential for triggering the clonal expansion of antigen-speciﬁc
B cells. However, a multitude of additional signals provided by
costimulatory molecules and cytokines may modify the outcome
of the B cell activation process (Bishop and Hostager, 2001).
One of the most important costimulatory molecule involved in
the T–B immune synapse is CD40, a member of the tumor necro-
sis factor (TNF) receptor family. Upon interaction with CD40L
(CD154), CD40 triggers signals that are crucial for many aspects
of B cell activation. For instance, in its absence, isotype switching,
germinal center formation, and memory B cell response are defec-
tive (Kawabe et al., 1994; Xu et al., 1994). By engaging CD28 on
naïve T cells, CD80 and CD86 are essential for naive T cell acti-
vation (Jenkins et al., 1991). Some experiments provide evidence
that signaling through CD80 and CD86 may also inﬂuence the
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outcome of the B cell response and in particular enhances IgG
secretion (Suvas et al., 2002; Rau et al., 2009). Another member
of the CD28 family, the inducible T cell costimulator molecule
(ICOS) is highly expressed on the surface of follicular helper T
cells (TFH), a subset of T cells found within B cell follicles and
responsible for the activation of germinal center B cells (Hutloff
et al., 1999; Greenwald et al., 2004). Its interaction with ICOS-
Ligand (ICOSL) on the surface of B cells has been implicated in
many aspects of the humoral response. Indeed, ICOSL deﬁcient
mice present a deﬁcit in isotype switching, antibody secretion, and
germinal center formation (Mak et al., 2003). OX-40, a member
of the TNFR family seems also to be speciﬁcally required for the
generation of an effective secondary B cell activation (Stuber and
Strober, 1996).
Strikingly,when linker for activation of T cell (LAT) is mutated,
the T cellmediated control of B cell activation is disrupted. LAT is a
transmembrane adaptor protein that constitutes amajor transduc-
tion hub of the TCR signaling cassette. Upon TCR engagement,
different tyrosines present in the LAT cytoplasmic tail become
phosphorylated and give rise to the formation of a multipro-
tein complex called the LAT signalosome and that is responsi-
ble for triggering downstream signaling events (Malissen et al.,
2005; Fuller and Zhang, 2009) The thymus of mice in which
the tyrosine residue found at position 136 has been replaced by
a phenylalanine (LatY136F) presents a severe but partial block-
ade in αβ T cell development (Aguado et al., 2002; Sommers
et al., 2002). However, the few CD4+ T cells able to reach the
periphery of LatY136F mice embark on a rapid and uncontrolled
expansion, giving rise to a massive enlargement of the secondary
lymphoid organs. These expanding T cells exhibit an activated-
effector and memory phenotype (CD25−, CD44high, CD62Llow,
CD69+) and produce large amounts of type 2 (TH2) cytokines,
particularly IL-4 and IL-10 and to a lesser extent, IL-5, IL-13, and
IFN-γ. Recent experiments suggested that the generation of the
LATY136F CD4+ T cell pathological expansion likely occurs in two
phases (Roncagalli et al., 2010). During the initiation phase, TCR
and CD28 engagement are important to trigger the activation
of the CD4+ T cells and the onset of the disease (Mingueneau
et al., 2009). In the presence of LATY136F molecules, the acti-
vated CD4+ T cells undergo a conversion into cells that express
low amount of TCR and are hypo-responsive to TCR signaling.
During a second phase called the perpetuation phase, the con-
verted CD4+ T cells continuously proliferate at a slower rate in
an MHCII independent-, IL-7 dependent-manner (Wang et al.,
2008).
This population of TH2 activated LatY136F CD4+ T cells leads
to the generation of an exaggerated yet normal sequence of B cell
activation. Indeed, all the typical B cell subsets induced during
a physiological T-dependent B cell activation, such as germi-
nal center B cells, antibody-secreting cells, and memory B cells
are evenly expanded in LatY136F mutant mice (Genton et al.,
2006). This activation results in a massive increase of IgG1 and
IgE leading to autoimmune disorders and inﬂammatory diseases
(Aguado et al., 2002; Genton et al., 2006). Given that both the
kappa and lambda light chain concentrations increase proportion-
ally, this hypergammaglobulinemia is likely due to a polyclonal,
antigen-independent driven B cell proliferation (Genton et al.,
2006). Further experiments have shown that, although early B
cell progenitors express LAT (Oya et al., 2003), the polyclonal B
cell activation observed in LatY136F mutant mice does not require
the expression of the LatY136F mutation in B cells. The LatY136F
mutation has only an indirect effect on B cells that is due to the
abnormal CD4+ T cells that develop in its presence (Genton et al.,
2006). Consistent with this view, when LatY136F CD4+ T cells are
adoptively transferred in Cd3εΔ5/Δ5 mice that lack T cells but con-
tain normal numbers of B cells, the host B cells become activated,
further demonstrating that theLatY136F mutation is not required in
B cells to render them susceptible to activation by LatY136F CD4+ T
cells (Wang et al., 2008). Importantly, transfer of LatY136F CD4+ T
cells into Cd3εΔ5/Δ5 host that lack MHCII molecules showed that
they are still capable of activating MHCII deﬁcient B cells (Gen-
ton et al., 2006). The mechanism leading to the B cell activation in
the context of the LAT pathology remains, however, elusive and it
is of interest to understand how LatY136F CD4+ T cells activate B
cells in absence of MHCII:TCR interaction. This study provides an
insight into the different costimulatorymolecules that are required
to trigger the massive B cell activation mediated by LatY136F CD4+
T cells both in vitro and in vivo.
MATERIALS AND METHODS
MICE
LatY136F mice and Cd3εΔ5/Δ5 mice have already been described
(Malissen et al., 1995; Aguado et al., 2002). Cd80−/−/Cd86−/−
mice were obtained from the Jackson Laboratory (Bar Harbor,
ME, USA), Cd40−/− mice (Kawabe et al., 1994) from A. Rolink
(Developmental and Molecular immunology Department, Klin-
isch Biologische Wissenschaften, Basel, Switzerland), and Icosl−/−
mice (McAdam et al., 2001) from M. Bachmann (Cytos Biotech-
nologyAG,Zurich, Switzerland). Cd28−/− (Shahinian et al., 1993)
and Icos−/− (Tafuri et al., 2001) mice were from T. Mak and A.
Tafuri (Ontario Cancer Institute, Toronto, Canada). LatY136F and
Cd3εΔ5/Δ5 mice deﬁcient for CD28, ICOS,CD80–CD86,CD40, or
ICOSL were derived in parallel using CD28, ICOS, CD80–CD86,
CD40, and ICOSL deﬁcientmice, respectively. Allmice weremain-
tained at CIML and the Swiss Institute for Experimental Cancer
Research speciﬁc pathogen free animal facility. All experiments
were done in agreement with Institutional and Swiss regulations
and with French directives.
ADOPTIVE TRANSFER
CD4+ T cells were isolated from spleen and lymph nodes of
5- to 8-week-old WT or LatY136F mice using CD4 conjugated
magnetic microbeads (Miltenyi Biotech) according to manufac-
turer instructions. In order to reduce the contamination with
WT B cells, LatY136F CD4+ T cells were isolated from young
LatY136F B cell deﬁcient mice. A total of 3 × 106 CD4+ T cells
(purity> 95%) was injected i.v. into 6- to 8-week-old Cd3εΔ5/Δ5,
Cd3εΔ5/Δ5 Cd80–/–/Cd86–/–, Cd3εΔ5/Δ5 Cd40–/–, or Cd3εΔ5/Δ5
Icosl–/– mice. When indicated, puriﬁed CD4+ T cells were labeled
during 10min at 37˚C in PBS containing CFSE (5μM; Molecular
Probes, Invitrogen) before injection. Peripheral blood lympho-
cytes (PBL)were harvested at indicated time points andCFSE con-
tent was analyzed by ﬂow cytometry after gating on CD4+CD5+
T cells.
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IN VITRO CO-CULTURE ASSAY
CD4+ Tcellswereﬁrst enrichedbyMACS(MiltenyiBiotech)using
anti-CD4 beads and then sorted by FACS for maximal purity (at
least 99%).A total of 3× 104 CD4+ cells was culturedwith 9× 104
splenocytes of the indicated genotype in 200μl of DMEM (Invit-
rogen Life Technologies) complemented with 10% FCS (Brun-
schwig), 10mM HEPES buffer (Invitrogen Life Technologies),
200μg/ml gentamicin (Invitrogen Life Technologies), and 50μM
2-ME (Invitrogen Life Technologies). When indicated, anti-
CD80 (5μg/ml), anti-CD86 (10μg/ml), anti-OX-40L (10μg/ml),
anti-IL-4 (10μg/ml), anti-CD4 (25μg/ml), and anti-LFA-1
(25μg/ml), were added to the culture medium. At the speciﬁed
time points, IgG1 was quantiﬁed in culture supernatants by ELISA.
FLOW CYTOMETRY
Single-cell suspensions from spleen, lymph nodes, thymus, and
bone marrow were stained for 20min with the indicated Abs
in presence of 50% 2.4G2 (anti-Fc) supernatant in PBS–FCS
3% EDTA 2mM. The following antibodies were used: anti-
B220 (RA3-6B2; eBioscience), anti-ICOS (15F9; eBioscience),
anti-MHCII (2G9; BD Pharmingen), anti-CD138 (281-2; BD
Pharmingen), anti-GL-7 (Ly77; BD Pharmingen), PNA (Sigma-
Aldrich), anti-CD3 (145-2C11; eBioscience), anti-CD4 (GK1.5;
BD Pharmingen), anti-CD5 (53-7-3; Biolegend), anti-CD8 (53-
6.7; Biolegend), anti-CD25 (PC61; Biolegend), anti-CD28 (37.51;
BD Pharmingen), anti-CD40L (MR1; Biolegend), anti-CD44
(IM7 eBioscience), anti-CD62L (MEL-14; eBioscience), anti-
CD69 (H1.2F3; BD Pharmingen), anti-CD95 (JO2; BD Pharmin-
gen), anti-CD134 (OX-86; BD Pharmingen), anti-CXCR5 (2G8,
BD Pharmingen), and anti-PD-1 (RPM1-30; Biolegend). Biotiny-
lated Abs were visualized with streptavidin–APC (Caltag Labora-
tories) or streptavidin–PE-Cy5.5 (eBioscience). For intracellular
staining, cells were subsequently ﬁxed with paraformaldehyde 1%
and stained in PBS–FCS 3% saponin 0.5% with the antibody of
interest. Cells were analyzed on a FACSCanto® cell analyzer (BD
Bioscience). FACS data were subsequently analyzed on FlowJo
(Tree Star).
IMMUNOHISTOLOGICAL ANALYSES
Lymph nodes or spleen were embedded in OCT parafﬁn (Tis-
sueTek). Immunostainings were performed on acetone-ﬁxed
frozen sections using standard methods with biotinylated anti-
B220 (RA3-6B2; Caltag Laboratories), anti-CD4 (RM4-5; eBio-
science) culture supernatant, anti-CD8 (53-6.7; eBioscience), and
biotinylated peanut agglutinin (PNA; Sigma-Aldrich). Biotiny-
lated anti-B220 was detected using alkaline phosphatase (AP)-
conjugated streptavidin (Boehringer Mannheim) and subsequent
incubation with Fast Blue BB salt (Sigma-Aldrich). Biotinylated
PNA and CD45.2 were revealed using HRP-conjugated strep-
tavidin and rat Abs using HRP-conjugated goat anti-rat Abs
(Biosource International). The substrate used for HRP was 3,3′-
diaminobenzidine/urea tablets (Sigma-Aldrich) complemented
withhydrogenperoxide.When required, counterstainingwas done
using Mayer’s hematoxylin.
ANALYSIS OF ANTIBODY TITERS
Levels of total IgM, IgG1, and IgE Abs present in mouse sera
or in co-culture supernatant were quantiﬁed by ELISA using
biotinylated polyclonal goat Abs speciﬁc for mouse Ig iso-
types (Caltag Laboratories). Detection was performed using
Streptavidin–HRP and Sigma Fast o-phenylenediamine (OPD;
Sigma-Aldrich). Immunoglobulin concentration was determined
by comparing a test sample dilution series with that using a isotype
control standard (Biolegend).
RESULTS
COSTIMULATORY MOLECULES ARE DIFFERENTIALLY REQUIRED FOR
LatY136F CD4+ T CELL MEDIATED B CELL ACTIVATION IN VITRO
Recent experiments have shown that CD4+ T cells isolated from
LatY136F mice and cultured in the presence of WT splenocytes
are able to induce a strong B cell activation as monitored by
immunoglobulin production (Genton et al., 2006). Moreover, this
activation occurs regardless of the occurrence of TCR:MHCII
interactions since MHCII deﬁcient splenocytes could still be acti-
vated by LatY136F T cells (Genton et al., 2006). The LatY136F CD4+
T cells harbored a typical activated phenotype characterized by a
strong up-regulation of CD44 and a down-regulation of CD62L
whereas the level of TCR–CD3 complexes was greatly reduced
(Aguado et al., 2002; Wang et al., 2008; Figure 1A).
To better characterize the process by which LatY136F T cells efﬁ-
ciently activate B cells in the absence of TCR:MHCII interaction,
the expression proﬁle of molecules present on the surface of T cells
and known to be involved in T–B cell interaction was investigated
by ﬂow cytometry. Both WT and LatY136F CD4+ T cells expressed
similarly high level of LFA-1. The levels of CD28, CD69, and
CD40L were slightly increased on LatY136F CD4+ T cells as com-
pared to WT T cells whereas the expression of ICOS and OX-40
was strongly increased in LatY136F CD4+ T cells (Figure 1A).
Given the high expression level of ICOS on the surface of
LatY136F CD4+ T cells and their potency to induce high level
of IgG1 and IgE, we determined whether these cells have a TFH
cell phenotype characterized by PD-1 and CXCR5 co-expression
(Breitfeld et al., 2000;Haynes et al., 2007). FACS analysis on lymph
node cell suspension revealed that the frequency of CXCR5+PD-
1+ cells was increased in LatY136F CD4+ T cells as compared to
the WT CD4+ T cells (Figure 1B). Moreover, after transfer into
WT recipient, the LatY136F CD4+ T cells migrated preferentially
into B cell follicles, where they were able to survive for over a
month without proliferating (Figure A1 in Appendix and data not
shown).
To further investigate which costimulatory molecules are
required to induce B cell activation by LatY136F CD4+ T cells, the
latter cells were co-cultured with splenocytes deﬁcient for CD40,
ICOSL, or for both CD80 and CD86. Analyses of the levels of IgG1
present in the supernatant after 6 days of culture showed thatCD80
and CD86 were important for B cell activation whereas CD40 and
ICOSLwere dispensable (Figure 1C). The differential requirement
of those molecules was further conﬁrmed by using blocking anti-
bodies (Figure 1D). Inhibition of either CD80 or CD86 led to a
partial blockade of IgG1 secretion whereas simultaneous blockade
of both CD80 and CD86 led to a more drastic inhibition. Blocking
the adhesion molecule LFA-1 abolished antibody production and
thus suggests that T–B cell contacts are likely required for the B cell
helper activity of LatY136F CD4+ T cells. IL-4, which is important
for isotype switching toward IgG1 was also required. Conversely,
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FIGURE 1 | Costimulatory molecules required for in vitro LatY136F T cell
mediated B cell activation. (A) Expression of costimulatory molecules on
the surface ofWT (gray) and LatY136F (solid line; CD8/CD4) lymph nodeT cells
investigated by ﬂow cytometry. (B) FACS analyses of lymph node fromWT
and LAT mutant mice using CD4 and B220. The frequency of TFH deﬁned as
PD-1+ CXCR5+ was also investigated among CD4 positive T cells. (C) IgG1
secretion was investigated by ELISA 6days after in vitro culture of LatY136F
CD4T cells in the presence ofWT splenocytes or of splenocytes deﬁcient for
the speciﬁed costimulatory molecules. Data are representative of at least
three independent experiments. (D) Effects of blocking antibodies on IgG1
secretion were assessed by ELISA 6days after co-culture of LatY136F CD4T
cells and ofWT splenocytes. Bar graph corresponds to mean±SD from three
independent experiments. MannWhitney test was performed to determine
whether differences were signiﬁcant. *p-Value<0.1; **p-value<0.05.
OX-40 inhibition did not prevent B cell activation. Altogether,
these in vitro data indicate that LatY136F CD4+ T cells activate B
cells through a synapse involving in particular CD80–CD86 and
cytokines such as IL-4, but this process is independent of CD40
and ICOSL signaling.
THE LatY136F MICE LYMPHOPROLIFERATIVE DISORDER UNFOLDS
IRRESPECTIVE OF ICOS, ICOSL, AND OF CD40 EXPRESSION
To determine whether the CD28, CD80, CD86, CD278 (ICOS),
and CD40 costimulatory molecules and the ICOSL costimu-
latory ligand were involved in the unfolding of the LATY136F
pathology, LatY136F mutant mice were crossed with Cd28−/−,
Cd80−/−/Cd86−/−, Icos−/−, Icosl−/−, and Cd40−/− mice to gener-
ate LatY136F mice deprived of CD28, CD80–CD86, ICOS, ICOSL,
or CD40. The size of the lymph nodes and spleen of the var-
ious mutant mice was assessed at 8 weeks of age, a time when
the pathology is fully installed in LatY136F mice. Strikingly, the
absence of CD28 or of CD80–CD86 completely abrogated the
lymphadenopathy and splenomegaly that characterize LatY136F
mutant mice, whereas the absence of ICOS, ICOSL, or CD40
did not affect signiﬁcantly the magnitude of the lymphoprolifera-
tive disorder resulting from the presence of LATY136F molecules
(Figures 2A,B and data not shown). Therefore, in contrast to
ICOS/ICOSL and to CD40, the CD28 receptor, and its CD80–
CD86 ligand appear mandatory for the development of the LAT
pathology.
PERIPHERAL LatY136F CD4+ T CELL EXPANSION IS BLOCKED IN THE
ABSENCE OF CD28 SIGNALING
We next compared the frequencies of CD4+ and CD8+ T cells
present in the spleen of 8-week-old LatY136F Icos−/−, LatY136F
Icosl−/−, LatY136F Cd40−/−, LatY136F Cd28−/−, and LatY136F
Cd80−/−/Cd86−/− mice (Figure 3). The absence of ICOS, ICOSL,
and CD40 did not modify the aberrant CD4+–CD8+ T cell subset
distribution observed in secondary lymphoid organs of LatY136F
mutant mice. Indeed, the expanding T cells were dominated by
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CD4+ T cells whereas the frequency of CD8+ T cells was reduced
to almost undetectable levels (Figures 3A,B). The absolutenumber
FIGURE 2 | Analysis of the lymphoproliferation occurring in LatY136F
mutant mice deficient for a given costimulatory molecule.Total cell
number present in pooled inguinal, brachial, and axillary lymph nodes (A)
and spleen (B) of 8-week-oldWT (black bar) or LatY136F mutant mice (open
bar) that were additionally deﬁcient for the costimulatory molecule
speciﬁed below the bars. Bars represent the mean±SD from at least three
different mice analyzed in independent experiments. t -Test or Mann
Whitney test was performed to determine whether differences were
signiﬁcant. *p-Value<0.05; **p-value<0.01.
of CD4+ T cells found in LatY136F Icosl−/−, LatY136F Icos−/−, and
LatY136F Cd40−/− was increased about 10-fold, which correspond
to the increase observed in LatY136F mutant mice (Figures 3C,D).
Strikingly, in the absence of CD28 or of CD80–CD86, the fre-
quency of LatY136F mutant CD4+ T cells was reduced to very
low levels, reaching values lower than those observed in WT mice
deﬁcient for CD80–CD86. Conversely, LatY136F Cd28−/−, LatY136F
Cd80−/−/Cd86−/− mice showed percentages of CD8+ T cells that
were increased as compared to LatY136F, LatY136F Icosl−/−, and
LatY136F Cd40−/− mutantmice (Figures 3A,B). In termof absolute
number, both LatY136F Cd28−/− and LatY136F Cd80−/−/Cd86−/−
mice presented a 10-fold reduction of CD4+ T cells compared
to WT counterpart whereas the absolute CD8+ T cell number
was similar to the number present in WT (Figures 3C,D). The
higher proportion of CD8+ T cells in LatY136F mutant spleen in the
absence of Cd80−/−/Cd86−/− was further conﬁrmed by immuno-
histochemistry (FigureA2 inAppendix).Analysis of thymi from8-
week-old LatY136F Cd28−/− and LatY136F Cd80−/−/Cd86−/− mice
revealed that small numbers of CD4 single positive T cells were
still able to develop in the absence of CD28/CD80–CD86 signaling
(Figures 3A,B in Appendix). However, consistent with data based
on a model where CD4+ T cells expressed LATY136F mutant mole-
cules only once they have fully matured and reached the periphery
FIGURE 3 | Effect of costimulatory molecule deficiency on the presence
of CD4 and CD8T cell in LatY136F mutant mice. (A)The frequency of CD4
and CD8T cells present in the lymph node of 8-week-oldWT (upper row) or of
LatY136F mice (lower row) lacking the costimulatory molecule speciﬁed above
the dot plots was assessed by ﬂow cytometry (B)T cells from the spleen of
the speciﬁed 8-week-old mice were analyzed for the expression of CD4 and
CD8. The percentage of cells is shown in each quadrant [upper row (C)]. Total
number of CD4 and CD8T cells present in pooled inguinal, brachial, and
axillary lymph nodes (left column) and in the spleen (right column) ofWT
(black bar) and LatY136F mice (open bar) lacking the indicated costimulatory
molecules on the surface of B cells. (D) Absolute numbers of CD4 and CD8T
cells recovered per spleen of 8-week-old mice lacking the indicated
costimulatory molecule on the surface of T cells. Histogram corresponds to
the mean±SD of at least three mice analyzed in independent experiments.
t -Test or MannWhitney test was performed to determine whether
differences were signiﬁcant. *p-Value<0.05; **p-value<0.01.
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(Mingueneau et al., 2009; Roncagalli et al., 2010), the CD4+ T cells
of both LatY136F Cd28−/− and LatY136F Cd80−/−/Cd86−/− mice
failed to proliferate extensively in secondary lymphoid organs.
Importantly, LatY136F mutant mice that were genetically deprived
of B cells were still able to develop a fully ﬂedged lymphoprolif-
erative disorder involving CD4+ Th2 effectors (our unpublished
observations). Therefore, the expansion of LatY136F CD4+ T cells
in the periphery requires CD28 crosslinking by CD80–CD86
through a process that is independent on B cells and most likely
involves dendritic cells.
SURFACE PHENOTYPE OF THE T CELLS EXPANDING IN THE PERIPHERY
OF LatY136F IN ABSENCE OF COSTIMULATORY MOLECULES
The phenotype of the T cells found in the periphery of LatY136F
Icos−/−, LatY136F Icosl−/−, LatY136F Cd40−/−, LatY136F Cd28−/−,
and LatY136F Cd80−/−/Cd86−/− mice was next compared to that
found in age-matched LatY136F mice (Figure 4 and data not
shown). No major differences were found when the CD4+ T cells
that expand in LatY136F, LatY136F Icosl−/−, and LatY136F Cd40−/−
were analyzed for the presence of CD62L, CD44, CD5, CD134
(OX-40), and ICOS and only a slight defect in the up-regulation of
CD134 was observed in the absence of CD40 (Figure 4). Absence
of CD80–CD86 led to a more drastic modiﬁcation of the phe-
notype of the few CD4+ T cells that are found in the periphery
of LatY136F Cd80−/−/Cd86−/− mice. Although those cells showed
reduced levels of TCR–CD3 complex at their surface, an attribute
that typiﬁesLatY136F CD4+ Tcells, they failed toup-regulateCD44,
CD134, and ICOS and to down regulate CD62L (Figure 4). The
CD8+ T cells present in the periphery of LatY136F Cd28−/− also
showed reduced levels of TCR–CD3 complexes at their surface
(data not shown). Therefore, the presence of CD28 or of CD80–
CD86 is required both for the expansion of the CD4+ T cells and
the induction of an activated phenotype.
EFFECT OF COSTIMULATORY MOLECULE DEFICIENCY ON B CELL
ACTIVATION
We next sought to determine whether the absence of the ICOS,
ICOSL, CD40, CD28, and CD80–CD86 costimulatory molecules
affects the massive B cell activation that is triggered by LatY136F
CD4+ T cells. As expected, the lymph nodes and the spleen of 8-
week-old LatY136F mice are characterized by a strong induction of
germinal center B cells characterized by a high expression level of
both PNA and GL-7 (Figure 5A and data not shown). Such cells
were also observed in LatY136F Icosl−/− mutant mice although with
a lower frequency. In marked contrast, no germinal center B cells
were identiﬁed in LatY136F mice lacking either CD40 or CD80–
CD86 (Figure 5A; Figure A4 in Appendix). The more differenti-
ated population of antibody-secreting cells present in WT lymph
nodes is characterized by a high expression of CD138 and reduced
levels of B220. This population was strongly increased in LatY136F
and in LatY136F Icosl−/− mice (Figure 5B). In the absence of CD40
or of CD80–CD86, such CD138+ B220− cells were almost com-
pletely absent. In LatY136F mice, the absolute number of CD138+
B220− cells showed a 1000-fold increase when compared to WT
mice and such massive increase was also observed in LatY136F
Icosl−/− mice (Figures 5C,D, left graph). The increase in antibody-
secreting cell population due to the LatY136F mutationwas strongly
FIGURE 4 | Phenotype of LatY136F CD4T cells in the absence of
costimulatory molecules. FACS analysis of the surface phenotype of CD4
T cell expanding in the lymph nodes of 2-month-oldWT (gray histogram)
and of LatY136F mice (open histogram) deﬁcient for the costimulatory
molecules speciﬁed above the histograms. FACS plot are representative of
at least three independent experiments.
reduced in the absence of CD40, where only a 10-fold increase in
the absolute number of CD138+ B220− could be observed and
such increase was almost completely abolished in the absence
of CD80–CD86. The same trend was observed when antibody-
secreting cells were enumerated in the spleen. However, the differ-
ences observed between the differentmice analyzedwere of a lower
magnitude than those observed in lymph nodes (Figures 5C,D,
right graph). Altogether, these results show that the whole B cell
activation process is impeded in the absence of CD80–CD86, an
observation consistent with the absence of activated CD4+ T cells.
In the absence of CD40, the total lack of germinal center formation
coexists with a small increase in the number of antibody-secreting
cells present in the spleen and lymph node. This suggests that
only the follicular pathway of B cell differentiation is abrogated.
Finally, the absence of ICOSL only marginally affects the capacity
of LatY136F CD4+ T cells to induce massive B cell activation.
ANTIBODY SECRETION IN THE ABSENCE OF COSTIMULATORY
MOLECULES
The LATY136F pathology is characterized by a massive increase
in antibody secretion, especially in immunoglobulins of the IgE
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FIGURE 5 | B cell activation observed in the periphery of LatY136F mutant
mice deficient for a given costimulatory molecule. (A) Frequency of
B220+ GL-7+ PNA+ cells found in pooled inguinal, axillary, and brachial lymph
nodes from 8-week-oldWT (left column) or LatY136F mutant mice (right
column) deﬁcient for the indicated costimulatory molecule. (B) Frequency of
CD138+ and B220+ cells found in pooled inguinal, axillary, and brachial
lymph nodes from 8-week-oldWT (left column) or LatY136F mutant mice (right
column) deﬁcient for the indicated costimulatory molecule. (C)Total number
of B220+ cells present in pooled inguinal, brachial, and axillary lymph nodes
(left column) and in the spleen (right column) ofWT (black bar) and LatY136F
mice (open bar) lacking the indicated costimulatory molecule. (D)Total
number of CD138+ cells present in pooled inguinal, brachial, and axillary
lymph nodes (left column) and in the spleen (right column) ofWT (black bar)
and LatY136F mice (open bar) lacking the indicated costimulatory molecule.
Histogram corresponds to the mean±SD of at least three mice analyzed in
independent experiments. t -Test or MannWhitney test was performed to
determine whether differences were signiﬁcant. *p-Value<0.05;
**p-value<0.01.
and IgG1 isotypes (Aguado et al., 2002; Genton et al., 2006).
The level of IgM, IgG1 and IgE was assessed by ELISA in the
blood of 8-week-old LatY136F Icos−/−, LatY136F Icosl−/−, LatY136F
Cd40−/− LatY136F Cd28−/−, and LatY136F Cd80−/−/Cd86−/−,
mice. Increased levels of IgM secretion were noted in LatY136F,
LatY136F Cd40−/−, and LatY136F Icosl−/− LatY136F Cd40−/− mice.
In LatY136F mice lacking CD80–CD86, no increase over basal
levels of IgM was observed (Figure 6A). The level of IgG1
increased at least 100-fold in LatY136F Icosl−/− and in LatY136F
Cd40−/− mice and reached values close to those observed in
LatY136F mice. In contrast, LatY136F Cd80−/−/Cd86−/− showed
levels of IgG1 similar to WT mice (Figure 6A). Finally, IgE lev-
els were massively increased in LatY136F and in LatY136F Icosl−/−
mice, moderately increased in LatY136F Cd40−/− mice and unde-
tectable in LatY136F Cd80−/−/Cd86−/− (Figure 6A). Consistent
with the above results, the lack of ICOS had no effect on the
LatY136F IgG1 and IgE hypergammaglobulinemia whereas the lack
of CD28 prevented it (Figure 6B). In conclusion, ICOS and
ICOSL are dispensable for the induction of hypergammaglob-
ulinemia G1 and E in LatY136F mice whereas CD40 partially
decreased the IgE hypergammaglobulinemia while leaving the
IgG1 hypergammaglobulinemia unaffected. On the other hand,
absence of CD80–CD86 completely abolished the induction of
immunoglobulin secretion in LatY136F mice, an observation con-
sistent with the absence of an expanded population of CD4+
T cells.
UNFOLDING OF THE LatY136F PATHOLOGY UPON ADOPTIVE TRANSFER
INTO HOSTS LACKING COSTIMULATORY LIGANDS
LatY136F CD4+ T cells were not able to expand correctly in
the absence of CD28 or of CD80–CD86 molecules (Mingue-
neau et al., 2009), and such block prevented to analyze in vivo
the role played by the CD28–CD80–CD86 receptor–ligand pair
during LatY136F CD4+ T cell mediated B cell activation. To
circumvent this problem and to determine whether converted
LatY136F CD4+ T cells require costimulatory molecules to acti-
vate B cells, LatY136F CD4+ T cells were isolated from LatY136F
mice using MACS puriﬁcation and adoptively transferred into
Cd3εΔ5/Δ5 mice that were made additionally deﬁcient for a given
costimulatory molecule. Following adoptive transfer, the fre-
quency of LatY136F CD4+ T cells was monitored in the blood.
A massive expansion of the LatY136F CD4+ T cells ensued
during the ﬁrst month after transfer into Cd3εΔ5/Δ5 recipient
(Figure 7A). Transfer into bothCd3εΔ5/Δ5 Icosl−/− andCd3εΔ5/Δ5
Cd40−/− hosts resulted in an expansion that followed a pro-
tracted kinetics and lagged by a 40- and 50-day-delay, respec-
tively, behind the kinetics observed after transfer into Cd3εΔ5/Δ5
recipient. Importantly, when LatY136F CD4 T cells were trans-
ferred into Cd3εΔ5/Δ5 Cd80−/−/Cd86−/− mice, no expansion
ensued (Figure 7A). Immunoglobulin levels were monitored
over the same time period and compared to the basal levels of
immunoglobulins present in control hosts that have received no
LatY136F CD4+ T cells (Figure 7B). As expected, IgM, IgG1, and
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FIGURE 6 | Analysis of antibody production inWT and LatY136F
mutant mice lacking a given costimulatory molecule. (A)The level of
IgM, IgG1, and IgE was investigated by ELISA in the sera of 8-week-old
WT (black bar) and LatY136F mutant mice (open bar) deﬁcient for CD40,
CD80–CD86, or ICOSL. (B)The concentration of IgG1 and IgE found in
the serum of 8-week-oldWT (black bar) and LatY136F mutant mice (open
bar) deﬁcient for CD28 or ICOS. Bars represent the mean±SD from
three different mice. t -Test or MannWhitney test was performed to
determine whether differences were signiﬁcant. *p-Value<0.05;
**p-value<0.01.
FIGURE 7 | Expansion and B cell activation potential of LatY136F CD4T
cells transferred intoT cell deficient recipient lacking a given
costimulatory molecule. (A) MACS puriﬁed LatY136F CD4T cells (3×106)
were adoptively transferred into Cd3eΔ5/Δ5, Cd3eΔ5/Δ5Cd40−/−,
Cd3eΔ5/Δ5Cd80/Cd86−/−, and Cd3eΔ5/Δ5Icosl−/− recipient mice. Kinetic of
LatY136F CD4T cells expansion was monitored by ﬂow cytometry in the blood
of transferred mice at the indicated time points. Each point corresponds to
the mean±SD of three mice. t -Test was performed to determine whether
differences between transferred and non-transferred mice of the same
genotype were signiﬁcant. *p-Value<0.05; **p-value<0.01. (B) IgM, IgG1,
and IgE levels were monitored in the sera of transferred (open circle) and
control mice (black circle) at the indicated time points. Each point
corresponds to the mean±SD of three mice. t -Test was performed to
determine whether differences were signiﬁcant. *p-Value<0.05;
**p-value<0.01. (C) FACS analyses of B220+ and CD4+ cells observed in
the blood of transferred mice (upper row) 70 days after transfer. Expression
of CD62L and CD44 was subsequently investigated by ﬂow cytometry at the
surface of CD4+ cells (lower row). (D)WT or LatY136F CD4+ T cells (3×106)
were CFSE labeled and transferred into mice lackingT cells and deﬁcient for
CD40, CD80/86, or ICOSL. CFSE proﬁle ofWT (gray) and LatY136F transferred
cells (open histogram) identiﬁed as CD4+ CD5+ cells was established in the
blood 3 and 10 days after transfer in the indicated recipients.
IgE levels increased rapidly after transferring LatY136F CD4+ T
cells into Cd3εΔ5/Δ5 hosts. In Cd3εΔ5/Δ5 Cd40−/− mice, IgM
secretion was strongly delayed whereas IgG1 and IgE were not
induced. In Cd3εΔ5/Δ5 Cd80−/−/Cd86−/− mice, no increase over
basal immunoglobulin levels was noted. In Cd3εΔ5/Δ5 Icosl−/−
mice reconstituted with LatY136F CD4 T cells, a late increase in
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IgG1 and IgE levels was noted whereas IgM levels were only slightly
increased.
When recipient mice were sacriﬁced 8weeks after transfer, both
Cd3εΔ5/Δ5,Cd3εΔ5/Δ5 Icosl−/−, and Cd3εΔ5/Δ5 Cd40−/− mice had
enlarged spleens and lymph nodes (data not shown) whereas
Cd3εΔ5/Δ5 Cd80−/−/Cd86−/− had normal sized organs. LatY136F
CD4+ T cells were readily found in the enlarged spleens and lymph
nodes of Cd3εΔ5/Δ5, and Cd3εΔ5/Δ5 Icosl−/− mice and their phe-
notype corresponded to activated T cells with a CD44high and
CD62Llow phenotype (Figure 7C). Therefore, this adoptive trans-
fer model reproduced in a general manner what was observed in
the double mutant mice. However, since the transferred LatY136F
CD4+ T cells failed to expand in the absence of CD80–CD86, such
system precluded the deﬁnitive conclusion to be reached on the
role played by theCD28–CD80–CD86 receptor–ligandpair during
LatY136F CD4 T cell mediated B cell activation.
CELL DIVISION OF TRANSFERRED CELLS AT EARLY TIME POINTS AFTER
TRANSFER
To determine how the absence of a given costimulatory mole-
cule might affect the initial expansion of LatY136F CD4+ T cells
that follows their adoptive transfer into Cd3εΔ5/Δ5 mice, WT, and
LatY136F CD4+ T cells were labeledwith theCFSEdivision tracking
dye before i.v. injection into Cd3εΔ5/Δ5 hosts that were deﬁcient
in such costimulatory molecules. The number of divisions was
assessed 3 and 10 days after transfer. No major difference in CFSE
dilution was observed in the absence of ICOSL, CD40, or CD80–
CD86 molecules 3 days after transfer. As previously described
(Wang et al., 2008), 10 days after transfer, WT CD4+ T cells went
already through a large number of divisions in a process which has
been shown to be MHCII-dependent and results in a single peak
of CFSE negative cells (Wang et al., 2008; Figure 7D, lower row,
ﬁrst graph, gray histogram). Upon transfer, a fraction of converted
LatY136F CD4+ T cells underwent a slower, MHCII independent,
and IL-7 dependent division process (Wang et al., 2008), and as a
result, remained CFSE positive 10 days after transfer (Figure 7D,
lower row, ﬁrst graph, open histogram). The absence of CD80–
CD86 impeded this explosive,MHCII-dependent division process
and a substantial number of CD4+ T cells remainedCFSE positive.
In the absence of CD40 or of ICOSL, a major CFSE positive peak
was still observed 10 days after transfer. Therefore, the absence
of ICOSL or of CD40 delayed the rate at which the transferred
LatY136F CD4+ T cells enter into cell cycle whereas the lack of
CD80–CD86 almost completely abolished it.
DISCUSSION
Although numerous studies have investigated the development of
LatY136F CD4+ T cells and their role in generating a TH2 lympho-
proliferative disorder, little is known of the mechanism leading
to the massive B cell activation associated with such disorder.
However, it is known that the underlying mechanisms do not
require TCR:MHCII interactions (Genton et al., 2006). This study
aimed therefore at elucidating which TCR-independent signals
are important to trigger the B cell activation induced by LatY136F
CD4+ T cells both in vitro and in vivo. Firstly, we demonstrated
in vitro that prolonged cell–cell interaction between B and T cells
is required since LFA-1 blockade impedes B cell activation. Next,
we assessed the role of molecules suspected of being involved in
the synapse between LatY136F CD4+ T cells and B cells. CD40 was
a possible candidate since anti-CD40 antibodies is widely used
in vitro as a potent signal to induce B cell activation in the absence
of MHCII signaling. Another candidate, ICOS, which is essential
for an efﬁcient TH2 response and high IgG1 and IgE secretion, is
strongly up regulated on the surface of LatY136F CD4+ T cells. We
hypothesize therefore that CD40 and ICOSL would be required to
enable LatY136F CD4+ T cells to trigger B cell activation. However,
in our in vitro settings, B cell activation monitored by IgG1 secre-
tion was not affected by the absence of CD40 signaling. Also, the
inhibition of OX-40, anothermolecule involved in late B cell differ-
entiation failed to block the B cell activation triggered by LatY136F
CD4+ T cells. This suggests that in the LatY136F pathology, alter-
native T cell molecules may be involved in B cell activation and
differentiation.
The cell surface molecules CD80 and CD86 are known to play
an important role in T cell activation by engaging the CD28 cos-
timulatory molecule. But their actual role during B cell activation
remains less well established. It has been shown that monoclonal
antibodies directed against CD80 block the immunoglobulin
secretion of LPS-stimulated B cells whereas anti-CD86 antibodies
have an opposite effect (Suvas et al., 2002). More recently, another
study showed that CD86 engagement induces XBP-1 expression
and promotes IgG secretion (Rau et al., 2009), suggesting that
CD86 could be the primary target of LatY136F CD4+ T cells at the
surface of B cells. Strikingly, in our in vitro settings, the use of anti-
CD80 or anti-CD86 blocking antibodies signiﬁcantly decreased
the immunoglobulin secretion induced by LatY136F CD4+ T cells,
while the combination of both of these antibodies almost com-
pletely blocked antibody production. Moreover, this result was
further conﬁrmed using CD80–CD86 deﬁcient B cells. In this case,
however, and in all subsequent in vivo experiments, the function
of these molecules was not assessed individually. Although it has
already been shown that CD86 is involved in B cell activation, the
level of magnitude of the inhibition observed here in the absence
of the CD80–CD86 costimulation represents a previously unex-
pected role for thesemolecules during B cell activation. Coupled to
the absence of role for ICOSL and CD40, this observation suggests
that LatY136F CD4+ T cells rely on an unusual combination of
costimulatory molecules to trigger B cell activation (Figure 8).
However, the role played by the CD28–CD80–CD86 receptor–
ligand pair in the LatY136F pathology may be more complex.
For example, it is possible that by engaging CD28, CD80–CD86
could induce the up-regulation of other essential molecules on the
surface of T cells that lead to complete B cell activation.
To conﬁrm these unexpected ﬁndings in vivo, LatY136F mutant
mice were crossed with mice deﬁcient for costimulatory mole-
cules. Importantly, this system is not affected by the fact that these
mice also display the LatY136F mutation in B cells, since it has been
shown that LAT is undetectable at later stages of B cell develop-
ment and its absence has no measurable effect on B cell activation
or differentiation (Oya et al., 2003; Su and Jumaa, 2003; Wang
et al., 2005). However, this system was not as tractable as origi-
nally expected since in the absence of CD28 or of CD80–CD86,
LatY136F CD4+ T cell development and activation was compro-
mised. Indeed, CD4+ T cells did not expand in the periphery and
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FIGURE 8 | Unusual combination of costimulatory molecules involved in
LATY136F CD4+ T cell mediated B cell activation. (A) Schematic
representation of ligand–receptor pairs required for the regulation of B cell
function byT lymphocytes. (B) In presence of LATY136F mutant CD4+ T cells,
many of these signals are bypassed. B cell activation can occur in absence of
antigen-speciﬁc interaction mediated by MHCII:TCR recognition. The resulting
polyclonal B cell activation is only slightly affected by the absence of CD40,
IL-4, OX-40 signaling, while CD80/86 and LFA-1 are critical in this process.
CTLA4, cytotoxic T lymphocyte antigen 4, ICAM1, intercellular adhesion
molecule; LFA-1, Lymphocyte function associated antigen 1; SMAC,
supramolecular activation complex; TCR, T cell receptor. (Adapted from Huppa
and Davis, 2003).
on the contrary, a population of CD8+ T cells was observed. This
conﬁrms previous observation suggesting that the very low num-
ber of CD4+ T cells able to reach the periphery in LatY136F mice
need to receive a signal throughCD28 for the onset of the initiation
phase of the LAT pathology (Mingueneau et al., 2009; Roncagalli
et al., 2010).
Nevertheless, our experimental model was suitable to investi-
gate the function of both CD40 and ICOSL since their absence did
not affect the expansion of LatY136F CD4+ T cells. In the absence of
CD40 and ICOSL, LatY136F CD4+ T cells still managed to perform
tasks that are generally attributed during physiological immune
responses to the presence of CD40 and ICOSL. Although CD40
remained crucial for the generation of germinal center induced by
LatY136F CD4+ T cells, its absence did not inhibit isotype switch-
ing. Indeed, the immunoglobulin production was not limited to
IgM, as it is the case in CD40 deﬁcient mice that are known to
exhibit a hyper IgM syndrome and very low amount of IgG and
IgE. Strikingly, both IgG and IgE were strongly induced, indicat-
ing that CD40 deﬁcient B cells were still able to efﬁciently switch
their isotype once in the presence of LatY136F CD4+ T cells. This
CD40 independent isotype switching may be due to an excess of
BAFF and April, two molecules that are known to induce iso-
type switching in the presence of IL-4 and IL-10 (Litinskiy et al.,
2002), although this possibility has not been addressed directly
yet. The origin of these immunoglobulins remains elusive since
very low levels of CD138+ antibody-secreting cells were found in
the lymph nodes and in the spleen. This suggests that either these
cells harbor a different phenotype or that they migrate to or are
induced in other organs such as bone marrow. By comparison,
LatY136F Icosl−/− mice exhibit a lower frequency of germinal cen-
ter cells when compared to LatY136F mice. This could be explained
by the important role played by ICOS in IL-21 production, which
is required for the expansion and persistence of follicular T helper
cell generation and function (Vogelzang et al., 2008; Linterman
et al., 2010; Zotos et al., 2010). The large plasma cell accumulation
and the hypergammaglobulinemia that occur in LatY136F mutant
mice were not affected by the absence of ICOSL, indicating that
this molecule is not critical for these processes.
Transfer of converted LatY136F CD4+ T cells into Cd3εΔ5/Δ5
mice that are deﬁcient for T cells but harbor a normal compart-
ment of B cells enabled the measurement of the effects of mutant
T cells on B cells and revealed that MHCII is not required for the
perpetuation of the LatY136F pathology (Wang et al., 2008). Nev-
ertheless, upon transfer into Cd3εΔ5/Δ5 Cd80−/−/Cd86−/− mice,
LatY136F CD4+ T cells failed to expand. This indicated that CD80
and CD86 molecules are required not only for the initiation phase
of the LatY136F T cell expansion in the periphery but also for the
slow, MHCII independent CD4+ T cell expansion occurring in
the post-conversion, perpetuation phase. As a consequence of this
impeded T cell expansion, determining the direct role played by
CD80–CD86 on the massive polyclonal B cell activation in vivo
remains intractable.
In conclusion, this study helped in understanding how a sin-
gle point mutation in the LAT adaptor protein is able to induce
a polyclonal, “quasi mitogenic” B cell activation. As previously
suggested, LAT is expected to operate a negative regulatory loop
that controls conventional CD4+ T cell activation (Mingueneau
et al., 2009). When equipped with LATY136F molecules, periph-
eral CD4+ T cells acquire the capacity to massively activate B cell
in the absence of TCR:MHCII interaction. Here, we showed that
the need for ICOSL and CD40 is overcome in the context of the
LatY136F pathology. Conversely, CD80 and CD86 molecules are
mandatory for both in vitro immunoglobulin production and the
two phases of LatY136F CD4+ T cell expansion in the periphery. As
such, CD80 and CD86 stand as key players in the generation of the
LAT pathology. The possibility that other molecules are involved
remains, however, undetermined. In this context, the signaling
lymphocyte activating molecule (SLAM) was recently shown to
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be involved in T–B cell interaction and SLAM associated pro-
tein (SAP) is required to establish long duration T–B cell contact
required for the formation of the germinal center reaction (Qi
et al., 2008; Schwartzberg et al., 2009). IL-21, which is now known
to play an important role for both TFH cell generation and func-
tion, is also strongly implicated in B cell activation and plasma
cell differentiation. This raises the intriguing possibility that these
molecules are also involved in the B cell activation induced by
LatY136F CD4+ T cell and it could be of interest to investigate their
role in order to provide new insights into the pathways that trigger
B cell activation in the LatY136F mutant context. Indeed, despite
its artiﬁcial aspect, the LAT pathology could be a useful model to
help understand similar lymphoproliferative disorders occurring
in human, such as the idiopathic hypereosinophilic syndrome that
results from a primitive T cell disorder involving abnormal CD4+
T cells (Roufosse, 2009).
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APPENDIX
FIGUREA1 | Preferential migration of LAT CD4T cells into the follicles.
LAT CD4T cells were transferred intoWT recipient and their localization in the
spleen and in the lymph node was investigated at day 2 and 14 using the
congenic marker CD45.2 (brown). Nuclei were counter-stained with Mayer’s
hematoxylin (blue). Arrows indicate the location of transferred cells present in
the B cell follicles.
FIGUREA2 | Immunohistological analyses of lymph node sections from
8-week-oldWT, LatY136F, Cd80−/−Cd86−/−, and LatY136F Cd80−/−Cd86−/−
mice. Anti-B220 (blue) and anti-CD8 (brown; upper row) or anti-B220 (blue)
and anti-CD4 (brown) staining (lower row) show the B andT cell distribution.
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FIGUREA3 |Thymocyte development in LatY136F CD80−/−CD86−/− mice.
(A) CD4 and CD8 thymocyte distribution was investigated in the thymus from
8-week-oldWT and LatY136F mice deﬁcient for CD80 and CD86. (B) Cells from
thymi from 8-week-oldWT, LatY136F, Cd28−/−, and LatY136F Cd28−/− mice were
analyzed for expression of CD4 and CD8. The percentage of cells is shown in
each quadrant. Also shown is the expression of CD3 on the surface of total
thymocytes ofWT, LatY136F, Cd28−/−, and LatY136F Cd28−/− mice. Percentages of
CD3high T cells are indicated. Data are representative of three different mice.
FIGUREA4 | Germinal center formation in LatY136F mutant mice lacking
CD40. Lymph node sections from mice of indicated genotype were
analyzed by immunohistology for the presence of B220 (blue) and CD4
(brown) cells (upper row). Lymph node sections were also stained with
PNA (brown) and nuclei were counter-stained with Mayer’s hematoxylin
(blue; lower row).
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